Clinical Significance of Monitoring Plasma Levels of Psychotropic Drugs
- 1 January 1980
- book chapter
- Published by Wiley
- No. 74,p. 115-139
- https://doi.org/10.1002/9780470720578.ch8
Abstract
This chapter contains section titled: Biological Monitoring Observations on Children Undergoing Long-Term Treatment with Haloperidol or Chlorimipramine Observations in Adult Psychotic Patients Results of Studies of Chronically Ill Patients Discussion Acknowledgements References Discussion ReferencesKeywords
This publication has 13 references indexed in Scilit:
- Pharmacokinetics of Psychotropic Drugs in the Pediatric PatientPublished by S. Karger AG ,2015
- Blood Levels of Neuroleptic Drugs in Nonresponding Chronic Schizophrenic PatientsArchives of General Psychiatry, 1979
- High-Dose Propranolol in SchizophreniaThe British Journal of Psychiatry, 1979
- Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult menPsychopharmacology, 1979
- Haloperidol Plasma Level Monitoring in Pediatric PatientsTherapeutic Drug Monitoring, 1979
- Relation of Plasma Prolactin to Clinical Response in Schizophrenic PatientsArchives of General Psychiatry, 1978
- Plasma Level Monitoring of Antipsychotic DrugsClinical Pharmacokinetics, 1978
- Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administrationEuropean Journal of Pharmacology, 1977
- Clinical significance of plasma chlorpromazine levels I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatmentPsychological Medicine, 1976
- Effects of mode of management on plasma chlorpromazine in psychiatric patientsClinical Pharmacology & Therapeutics, 1973